Improving Conversations About Sexual Health After Gynecologic Cancer
Official title: Promoting Effective Clinical Communication about Sexual Health after Gynecologic Cancer: A Randomized Controlled Trial of a Patient-Focused Intervention
Funded at Research Inst of Fox Chase Can Ctr · NIH-11128829 · Data updated 2026-11-12
This project helps women who have had gynecologic cancer feel more confident and prepared to talk with their doctors about sexual health concerns.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Research Inst of Fox Chase Can Ctr NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project start | July 1, 2024 |
| Project end | June 30, 2029 |
| Funding year | 2025 |
| Award (this year) | $488,602 |
| NIH project number | 5R01CA285674-02 |
| Project ID | NIH-11128829 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates are female patients who have been treated for any stage of gynecologic cancer and are experiencing sexual health concerns.
✕Less likely to help
Patients who do not have gynecologic cancer or are not experiencing sexual health concerns related to their cancer treatment may not directly benefit from this specific intervention.
What this research studies
Many women face sexual health challenges after gynecologic cancer but find it hard to discuss these with their healthcare providers. This project offers a special program called Starting the Conversation – Gynecologic Cancer (STC-GC) to help women learn how to effectively bring up these important topics. The program aims to empower patients to lead discussions and ensure their needs are met. We want to see if this program truly helps women communicate better about their sexual health.
Why it matters
Potential benefit: If successful, this program could help women with gynecologic cancer feel more comfortable and prepared to discuss sexual health with their doctors, leading to better support and care for these concerns.
How similar studies have gone: A similar program was effective for breast cancer patients, and a pilot test of this modified program for gynecologic cancer patients showed it was feasible and well-received.
Where this research is happening
-
Research Inst of Fox Chase Can Ctr
Philadelphia, United States Active
Researchers
- Principal investigator: Reese, Jennifer Barsky — Research Inst of Fox Chase Can Ctr
- Study coordinator: Reese, Jennifer Barsky
Related research
Other NIH-funded projects on the same topics.
-
Promoting open talks about sexual health after gynecologic cancer
A patient-focused program helps women with gynecologic cancer start and guide conversations about sexual health with their doctors.
-
Improving communication about sexual health for women after gynecologic cancer treatment
This study is designed to help women who have been treated for gynecologic cancer talk more openly about their sexual health with their doctors, using a special program called Starting the Conversation – Gynecologic Cancer, to make these important discussions easier and less stressful.
-
Cognitive behavioral therapy and trazodone for insomnia phenotypes with high blood pressure
A clinical study tests how CBT-I and the sleep drug trazodone work for adults with insomnia and high blood pressure, focusing on a specific sleep duration pattern.
-
Shorter antifungal treatment for kids with candidemia
A multi-center pediatric trial tests whether a shorter, 7 extra days of antifungal therapy after an initial 7 days is just as good as the standard 14-day approach for kids with candidemia who are improving on echinocandin therapy.
-
Short Course vs Standard Course Antifungal Therapy for Pediatric Candidemia
This study tests whether a shorter 7-day total antifungal treatment after an initial 7 days of echinocandin therapy is as effective as the usual 14-day course for children with candidemia.
-
Shorter antifungal treatment for kids with candidemia
A multi-center study tests whether kids with candidemia can finish treatment earlier after an initial week of antifungal therapy than the standard two weeks total.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.